These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 9123372)

  • 41. Genetic regulation of the antibody response to H-2Db alloantigens in mice. IV. Antigens that activate helper T cells for IgG, coded for by the non-H-2 genome.
    Wernet D; Heinrichs H; Wernet P
    J Immunol; 1982 Jun; 128(6):2595-8. PubMed ID: 6176646
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Transplantation of cultured thymic fragments. VI. H-2 recombinant donors.
    Jenski LJ; Hong R
    J Immunol; 1985 Aug; 135(2):947-53. PubMed ID: 2409162
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Class I MHC antigens of different subregions induce different IgG subclasses.
    Tartakovsky B; De Baetselier P; Isakov N; Katzav S; Feldman M; Segal S
    J Immunol; 1983 Mar; 130(3):1017-8. PubMed ID: 6822731
    [No Abstract]   [Full Text] [Related]  

  • 44. Rapamycin suppression of host-versus-graft and graft-versus-host disease in MHC-mismatched rats.
    Fabian MA; Denning SM; Bollinger RR
    Transplant Proc; 1992 Jun; 24(3):1174. PubMed ID: 1604575
    [No Abstract]   [Full Text] [Related]  

  • 45. Tolerance in Mlsa mismatched chimeras prepared with allogeneic bone marrow alone or in combination with syngeneic bone marrow.
    Sefrioui H; Billiau AD; Overbergh L; Rutgeerts O; Waer M
    Transplant Proc; 1999; 31(1-2):702-3. PubMed ID: 10083303
    [No Abstract]   [Full Text] [Related]  

  • 46. Combined blockade of CD28/B7 and CD40/CD40L costimulatory pathways prevents the onset of chronic rejection.
    Subbotin V; Sun H; Chen C; Aitouche A; Valdivia L; Fung JJ; Starzl TE; Rao AS
    Transplant Proc; 1998 Jun; 30(4):941-2. PubMed ID: 9636378
    [No Abstract]   [Full Text] [Related]  

  • 47. Granulocyte-macrophage colony-stimulating factor-based melanoma cell vaccines immunize syngeneic and allogeneic recipients via host dendritic cells.
    Schneeberger A; Lührs P; Kutil R; Steinlein P; Schild H; Schmidt W; Stingl G
    J Immunol; 2003 Nov; 171(10):5180-7. PubMed ID: 14607918
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The effect of oral immunization on corneal allograft survival.
    He YG; Mellon J; Niederkorn JY
    Transplantation; 1996 Mar; 61(6):920-6. PubMed ID: 8623161
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Monoclonal antibodies to mouse major histocompatibility complex antigens.
    Ozato K; Mayer NM; Sachs DH
    Transplantation; 1982 Sep; 34(3):113-20. PubMed ID: 7135466
    [TBL] [Abstract][Full Text] [Related]  

  • 50. T lymphocyte responses to multiple minor histocompatibility antigens generate both self-major histocompatibility complex-restricted and cross-reactive cytotoxic T lymphocytes.
    Tremblay N; Fontaine P; Perreault C
    Transplantation; 1994 Jul; 58(1):59-67. PubMed ID: 8036709
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Immune response after syngeneic and allogeneic blood cell transplantation.
    Grzelak I; Zaleska M; Olszewski WL
    Transplant Proc; 1997 Jun; 29(4):2181-2. PubMed ID: 9193579
    [No Abstract]   [Full Text] [Related]  

  • 52. Why are systemic glioblastoma metastases rare? Systemic and cerebral growth of mouse glioblastoma.
    Mourad PD; Farrell L; Stamps LD; Chicoine MR; Silbergeld DL
    Surg Neurol; 2005 Jun; 63(6):511-9; discussion 519. PubMed ID: 15936366
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Split tolerance to the MHC class I molecule H-2Dd in animals transgenic for its soluble analog.
    Hunziker RD; Lynch F; Shevach EM; Margulies DH
    Hum Immunol; 1997 Feb; 52(2):82-94. PubMed ID: 9077557
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Non-MHC-linked genetic control of murine cytotoxic T lymphocyte responses to hapten-modified syngeneic cells.
    Arora PK; Shearer GM
    J Immunol; 1981 Nov; 127(5):1822-8. PubMed ID: 6975299
    [No Abstract]   [Full Text] [Related]  

  • 55. Inhibition of natural killer cell-mediated bone marrow graft rejection by allogeneic major histocompatibility complex class I, but not class II molecules.
    Ohlén C; Höglund P; Sentman CL; Carbone E; Ljunggren HG; Koller B; Kärre K
    Eur J Immunol; 1995 May; 25(5):1286-91. PubMed ID: 7774631
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Major histocompatibility complex-restricted and unrestricted T helper cells recognizing minor histocompatibility antigens of B cell surfaces.
    Coutinho A; Augustin AA
    Eur J Immunol; 1980 Jul; 10(7):535-41. PubMed ID: 6157541
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The nature of tolerance in adult recipient mice made tolerant of alloantigens with supralethal irradiation followed by syngeneic bone marrow cell transplantation plus injection of F1 spleen cells.
    Tomita Y; Himeno K; Mayumi H; Tokuda N; Nomoto K
    Transplantation; 1989 Jun; 47(6):1021-9. PubMed ID: 2660340
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Drug-induced tolerance to allografts in mice. VIII. Effects of thymectomy and/or splenectomy on tolerance induction in an H-2-haplotype-identical strain combination.
    Mayumi H; Himeno K; Tokuda N; Nomoto K
    Transplantation; 1985 Oct; 40(4):438-41. PubMed ID: 4049497
    [No Abstract]   [Full Text] [Related]  

  • 59. In vivo priming of mouse CTL precursors directed to product of a newly defined minor H-42 locus is under a novel control of class II MHC gene.
    Ishikawa H; Suzuki H; Hino T; Kubota E; Saito K
    J Immunol; 1985 Dec; 135(6):3681-5. PubMed ID: 3934264
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Mixed allogeneic chimerism in the rat. Donor-specific transplantation tolerance without chronic rejection for primarily vascularized cardiac allografts.
    Colson YL; Zadach K; Nalesnik M; Ildstad ST
    Transplantation; 1995 Nov; 60(9):971-80. PubMed ID: 7491703
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.